Aditya Birla Sun Life Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹815 Cr | ₹1208 Cr |
Min Investment | ₹1000 | ₹5000 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 10 Jul 2019 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 31% | 26.49% |
Expense Ratio | 2.27 | 2.14 |
Manager | Dhaval Joshi | Meeta Shetty |
ISIN Code | INF209KB1N91 | INF277K016A9 |
Exits Load | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 2.04% | 2.48% |
6 Month | -3.07% | -3.08% |
1 Year | 14.46% | 16.58% |
3 Year | 18.55% | 20.32% |
5 Year | 19.55% | 22.02% |
SIP Return Analysis
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 0.15% | 0.81% |
1 Year | 0.87% | 3.58% |
3 Year | 23.1% | 24.72% |
5 Year | 18.04% | 20.05% |
Rolling Lumpsum Returns
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 29.31% | 7.82% |
3 Year | 15.89% | 17.79% |
5 Year | 24.32% | 14.55% |
Risk Management
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 16.061% | 16.538% |
Sharp | 0.719% | 0.681% |
Beta | 0.98% | 0.969% |
Alpha | -1.737% | 0.018% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Dhaval Joshi | Meeta Shetty |
Total AUM | ₹361932 Cr | ₹17847 Cr |
Funds Managed | 55 | 5 |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 6.75 | 5.06 |
Large Cap | 34.78 | 35.26 |
Mid Cap | 37.07 | 31.87 |
Small Cap | 21.39 | 27.82 |
Sector Allocation
Scheme Name |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 5.74 | 4.34 |
Healthcare | 93.46 | 93.44 |
Basic Materials | 0.8 | 2.22 |
Top Comparisons
Tata Mid Cap Growth Fund Regular Plan- Growth Option
3Y Returns18.67%
Sundaram Mid Cap Fund Regular Plan - Growth
3Y Returns22.14%
Franklin Build India Fund Growth Plan
3Y Returns27.84%
ICICI Prudential Infrastructure Fund - Growth
3Y Returns28.07%
Kotak Equity Hybrid - Growth
3Y Returns13.86%
HSBC Aggressive Hybrid Fund - Regular Growth
3Y Returns12.04%
ICICI Prudential Large & Mid Cap Fund - Growth
3Y Returns21.26%
DSP Equity Opportunities Fund-Regular Plan - Growth
3Y Returns20.52%